flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic disease in the ADA 24: FLOW Trial: Kidney

For example, Rybelsus can cause an allergic reaction or inflammation of the pancreas, kidney or thyroid dysfunction, depression, or apathy

Clinical trial results The SURMOUNT clinical trial program demonstrated remarkable weight loss with tirzepatide

Fact 29: Smartphone neck posture problems affect 84% of frequent users, leading to chronic pain in 31% of cases (Posture and Technology Institute, 2023)

Patients with pre-existing gastrointestinal conditionsinflammatory bowel disease, irritable bowel syndrome, or previous bowel surgeryshould maintain closer monitoring and lower thresholds for seeking medical input, as these populations may experience more pronounced or complex digestive effects